BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32253709)

  • 21. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry.
    Avnery O; Martin M; Bura-Riviere A; Barillari G; Mazzolai L; Mahé I; Marchena PJ; Verhamme P; Monreal M; Ellis MH;
    J Intern Med; 2020 Jan; 287(1):32-41. PubMed ID: 31394000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study.
    Galanaud JP; Sevestre MA; Pernod G; Genty C; Richelet S; Kahn SR; Boulon C; Terrisse H; Quéré I; Bosson JL
    J Thromb Haemost; 2017 May; 15(5):907-916. PubMed ID: 28266773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.
    Michiels JJ; Moosdorff W; Maasland H; Michiels JM; Lao MU; Neumann HA; Dulicek P; Stvrtinova V; Barth J; Palareti G
    Int Angiol; 2014 Feb; 33(1):1-19. PubMed ID: 24452081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.
    Eichinger S; Heinze G; Kyrle PA
    J Am Heart Assoc; 2014 Jan; 3(1):e000467. PubMed ID: 24385451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prediction role of D-dimer in recurrence of venous thromboembolism 1-year after anticoagulation discontinuing following idiopathic deep vein thrombosis.
    Tamizifar B; Oghab P; Esfahani MA
    J Res Med Sci; 2014 Jul; 19(7):586-91. PubMed ID: 25364355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension.
    Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G;
    J Thromb Haemost; 2010 Sep; 8(9):1933-42. PubMed ID: 20553388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.
    Curtin N; Highe G; Harris M; Braunstein A; Demattia F; Coss L
    Lab Hematol; 2004; 10(2):88-94. PubMed ID: 15224764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of D-dimer testing: Good, Bad, and Ugly.
    Linkins LA; Takach Lapner S
    Int J Lab Hematol; 2017 May; 39 Suppl 1():98-103. PubMed ID: 28447414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
    Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
    Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience.
    Poudel SK; Park DY; Jia X; Wilks M; Pinkava V; O'Brien M; Tripp B; Song JM; McCrae KR; Khorana AA; Angelini DE
    J Thromb Haemost; 2020 Mar; 18(3):651-659. PubMed ID: 31808607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial Protocol: a randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study).
    Tullett J; Murray E; Nichols L; Holder R; Lester W; Rose P; Hobbs FD; Fitzmaurice D
    BMC Cardiovasc Disord; 2013 Mar; 13():16. PubMed ID: 23497371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the predictive value of D-dimer in patients with idiopathic venous thromboembolism.
    Cosmi B; Palareti G
    Thromb Res; 2010 Apr; 125 Suppl 2():S62-5. PubMed ID: 20434008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
    Shrivastava S; Ridker PM; Glynn RJ; Goldhaber SZ; Moll S; Bounameaux H; Bauer KA; Kessler CM; Cushman M
    J Thromb Haemost; 2006 Jun; 4(6):1208-14. PubMed ID: 16706961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis.
    Vlazny DT; Pasha AK; Kuczmik W; Wysokinski WE; Bartlett M; Houghton D; Casanegra AI; Daniels P; Froehling DA; White LJ; Hodge DO; McBane RD
    J Thromb Haemost; 2021 Sep; 19(9):2206-2215. PubMed ID: 34060224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-dimer testing to determine the duration of anticoagulation therapy.
    Palareti G; Cosmi B; Legnani C; Tosetto A; Brusi C; Iorio A; Pengo V; Ghirarduzzi A; Pattacini C; Testa S; Lensing AW; Tripodi A;
    N Engl J Med; 2006 Oct; 355(17):1780-9. PubMed ID: 17065639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unprovoked recurrent venous thrombosis: prediction by D-dimer and clinical risk factors.
    Baglin T; Palmer CR; Luddington R; Baglin C
    J Thromb Haemost; 2008 Apr; 6(4):577-82. PubMed ID: 18182040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
    Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
    Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
    Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
    PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study.
    van Hylckama Vlieg A; Baglin CA; Luddington R; MacDonald S; Rosendaal FR; Baglin TP
    J Thromb Haemost; 2015 Sep; 13(9):1642-52. PubMed ID: 26178257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.